ACOG/SMFM Update on Drug Product Recalls.

The U.S. Food and Drug Administration announced on October 31, 2012, that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation. Ameridose is a company sharing common management by the same parties as New England Compounding Center (NECC) of Framingham, Massachusetts, the firm associated with compounded drugs linked to the ongoing fungal meningitis outbreak.

Products from Ameridose can be identified by markings that indicate Ameridose by name or by its company logo . A complete list of all products subject to this recall can be accessed at http://cdn-ecomm.dreamingcode.com/public/195/documents/Version-20121031152001-Documents-195-1704-1.pdf. Ob-gyns should be aware that there are several products on this recall list that they might prescribe but  Hydroxyprogesterone caproate is not included on the list.

More information can be found at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326361.htm.